vs
BIOLIFE SOLUTIONS INC（BLFS）与FONAR CORP（FONR）财务数据对比。点击上方公司名可切换其他公司
FONAR CORP的季度营收约是BIOLIFE SOLUTIONS INC的1.4倍（$25.5M vs $18.8M）。BIOLIFE SOLUTIONS INC净利率更高（58.9% vs 8.0%，领先50.9%）。BIOLIFE SOLUTIONS INC同比增速更快（24.3% vs 2.4%）。过去两年BIOLIFE SOLUTIONS INC的营收复合增速更高（1.0% vs -0.3%）
BIOLIFE SOLUTIONS INC专注于开发生物保存产品及冷链管理解决方案，服务于细胞与基因治疗、生物制药及再生医学领域，产品涵盖低温保存培养基、自动化解冻系统、温度监测工具，为全球相关企业、科研机构及临床实验室提供支持。
FONAR是一家专业医疗技术企业，专注于设计、制造及销售包括立式、开放式在内的创新磁共振成像（MRI）设备，主要服务美国的医院、影像诊断中心及医疗机构，为临床诊断提供高精度扫描解决方案。
BLFS vs FONR — 直观对比
营收规模更大
FONR
是对方的1.4倍
$18.8M
营收增速更快
BLFS
高出21.9%
2.4%
净利率更高
BLFS
高出50.9%
8.0%
两年增速更快
BLFS
近两年复合增速
-0.3%
损益表 — Q4 2025 vs Q2 2026
| 指标 | | |
|---|---|---|
| 营收 | $18.8M | $25.5M |
| 净利润 | $11.1M | $2.1M |
| 毛利率 | — | — |
| 营业利润率 | 7.2% | 13.5% |
| 净利率 | 58.9% | 8.0% |
| 营收同比 | 24.3% | 2.4% |
| 净利润同比 | -11.1% | 4.7% |
| 每股收益（稀释后） | $0.23 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BLFSFONR
| Q4 25 | $18.8M | $25.5M | ||
| Q3 25 | $28.1M | $26.0M | ||
| Q2 25 | $25.4M | $27.3M | ||
| Q1 25 | $23.9M | $27.2M | ||
| Q4 24 | $15.1M | $24.9M | ||
| Q3 24 | $21.4M | $25.0M | ||
| Q2 24 | $19.7M | $25.9M | ||
| Q1 24 | $18.4M | $25.7M |
净利润BLFSFONR
| Q4 25 | $11.1M | $2.1M | ||
| Q3 25 | $621.0K | $2.3M | ||
| Q2 25 | $-15.8M | $729.3K | ||
| Q1 25 | $-448.0K | $2.5M | ||
| Q4 24 | $12.5M | $2.0M | ||
| Q3 24 | $-1.7M | $3.1M | ||
| Q2 24 | $-20.7M | $830.4K | ||
| Q1 24 | $-10.2M | $1.9M |
营业利润率BLFSFONR
| Q4 25 | 7.2% | 13.5% | ||
| Q3 25 | -0.3% | 14.1% | ||
| Q2 25 | -65.5% | 5.3% | ||
| Q1 25 | -5.1% | 15.2% | ||
| Q4 24 | 3.6% | 11.9% | ||
| Q3 24 | -2.0% | 21.0% | ||
| Q2 24 | -6.6% | 7.4% | ||
| Q1 24 | -17.9% | 16.8% |
净利率BLFSFONR
| Q4 25 | 58.9% | 8.0% | ||
| Q3 25 | 2.2% | 8.7% | ||
| Q2 25 | -62.3% | 2.7% | ||
| Q1 25 | -1.9% | 9.2% | ||
| Q4 24 | 82.5% | 7.9% | ||
| Q3 24 | -8.0% | 12.6% | ||
| Q2 24 | -105.1% | 3.2% | ||
| Q1 24 | -55.4% | 7.3% |
每股收益（稀释后）BLFSFONR
| Q4 25 | $0.23 | — | ||
| Q3 25 | $0.01 | — | ||
| Q2 25 | $-0.33 | — | ||
| Q1 25 | $-0.01 | — | ||
| Q4 24 | $0.27 | — | ||
| Q3 24 | $-0.04 | — | ||
| Q2 24 | $-0.45 | — | ||
| Q1 24 | $-0.22 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $33.0M | $121.0K |
| 总债务越低越好 | $5.0M | — |
| 股东权益账面价值 | $371.9M | $176.9M |
| 总资产 | $405.9M | $217.2M |
| 负债/权益比越低杠杆越低 | 0.01× | — |
8季度趋势，按日历期对齐
现金及短期投资BLFSFONR
| Q4 25 | $33.0M | $121.0K | ||
| Q3 25 | $29.5M | $122.0K | ||
| Q2 25 | $31.9M | $56.5M | ||
| Q1 25 | $66.9M | $123.0K | ||
| Q4 24 | $91.5M | $121.0K | ||
| Q3 24 | $24.0M | $136.0K | ||
| Q2 24 | $22.0M | $56.5M | ||
| Q1 24 | $29.7M | $134.0K |
总债务BLFSFONR
| Q4 25 | $5.0M | — | ||
| Q3 25 | $7.5M | — | ||
| Q2 25 | $10.1M | — | ||
| Q1 25 | $12.9M | — | ||
| Q4 24 | $15.9M | — | ||
| Q3 24 | $20.1M | — | ||
| Q2 24 | $21.1M | $66.9K | ||
| Q1 24 | $24.3M | — |
股东权益BLFSFONR
| Q4 25 | $371.9M | $176.9M | ||
| Q3 25 | $353.7M | $174.9M | ||
| Q2 25 | $347.2M | $172.6M | ||
| Q1 25 | $352.6M | $171.9M | ||
| Q4 24 | $348.9M | $169.8M | ||
| Q3 24 | $325.5M | $168.7M | ||
| Q2 24 | $321.4M | $166.0M | ||
| Q1 24 | $333.4M | $165.8M |
总资产BLFSFONR
| Q4 25 | $405.9M | $217.2M | ||
| Q3 25 | $392.1M | $218.4M | ||
| Q2 25 | $387.2M | $216.9M | ||
| Q1 25 | $395.1M | $214.9M | ||
| Q4 24 | $399.5M | $208.0M | ||
| Q3 24 | $381.7M | $212.3M | ||
| Q2 24 | $375.0M | $214.2M | ||
| Q1 24 | $401.6M | $209.6M |
负债/权益比BLFSFONR
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.02× | — | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.04× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.06× | — | ||
| Q2 24 | 0.07× | 0.00× | ||
| Q1 24 | 0.07× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.9M | $171.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-227.0K |
| 自由现金流率自由现金流/营收 | — | -0.9% |
| 资本支出强度资本支出/营收 | — | 1.6% |
| 现金转化率经营现金流/净利润 | 0.44× | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | $5.7M |
8季度趋势，按日历期对齐
经营现金流BLFSFONR
| Q4 25 | $4.9M | $171.0K | ||
| Q3 25 | $6.1M | $1.7M | ||
| Q2 25 | $7.4M | $4.2M | ||
| Q1 25 | $1.7M | $3.1M | ||
| Q4 24 | $1.6M | $2.2M | ||
| Q3 24 | $4.8M | $1.7M | ||
| Q2 24 | $6.5M | $4.6M | ||
| Q1 24 | $-4.5M | $2.8M |
自由现金流BLFSFONR
| Q4 25 | — | $-227.0K | ||
| Q3 25 | — | $-177.0K | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | — | $2.6M | ||
| Q4 24 | — | $1.5M | ||
| Q3 24 | — | $-148.0K | ||
| Q2 24 | — | $4.2M | ||
| Q1 24 | — | $2.6M |
自由现金流率BLFSFONR
| Q4 25 | — | -0.9% | ||
| Q3 25 | — | -0.7% | ||
| Q2 25 | — | 13.1% | ||
| Q1 25 | — | 9.4% | ||
| Q4 24 | — | 6.0% | ||
| Q3 24 | — | -0.6% | ||
| Q2 24 | — | 16.1% | ||
| Q1 24 | — | 10.2% |
资本支出强度BLFSFONR
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 7.2% | ||
| Q2 25 | — | 2.4% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | 7.2% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 0.7% |
现金转化率BLFSFONR
| Q4 25 | 0.44× | 0.08× | ||
| Q3 25 | 9.83× | 0.75× | ||
| Q2 25 | — | 5.79× | ||
| Q1 25 | — | 1.26× | ||
| Q4 24 | 0.13× | 1.14× | ||
| Q3 24 | — | 0.53× | ||
| Q2 24 | — | 5.54× | ||
| Q1 24 | — | 1.50× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BLFS
暂无分部数据
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
